Cue Biopharma, Inc.

CUENASDAQ • USD
5.39 USD
↘ 8.71 (61.80%)🟢LIVE (AS OF 01:31 PM EST)
🟢Market: OPEN

CUE is currently priced at $5.39. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Strong Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, CUE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 16, 2026.

Open?$13.02
High?$13.75
Low?$5.37
Prev. Close?$14.10
Volume?1.0M
Avg. Volume?165.0K
VWAP?$7.90
Rel. Volume?6.36x
Bid / Ask
Bid?$5.09 × 100
Ask?$6.83 × 100
Spread?$1.74
Midpoint?$5.96
Valuation & Ratios
Market Cap?102.4M
Shares Out?7.3M
Float?6.5M
Float %?89.7%
P/E Ratio?N/A
P/B Ratio?44.34
EPS?-$22.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Employees
29
Market Cap
102.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-01-02
Address
100 CHESTNUT STREET
SOMERVILLE, MA 02143
Phone: 617-949-2680
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
23
Short Sent.?
49
Piotroski F-Score?2/9Weak
Altman Z-Score?-31.01Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.24%High
Short Interest?862.8K
Days to Cover?7.6
Free Float6.5M
Avg Daily Volume114.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?0.82Adequate
Debt/Equity?0.42Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
3
44.34HIGH▾
P/S?
Peers
100
S&P
54
2.72CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
Peers
100
S&P
71
2.28CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-7,104.2%WEAK▾
ROA?
S&P
3
-534.4%WEAK▾
Cash Flow & Enterprise
FCF?$-50167000
Enterprise Value?$86.0M
Fundamentals ratios updated end of day